Cevimeline (FKS-508; SNI-2011; AF-102B; SNK-508; trade name Evoxac) is a potent parasympathomimetic and muscarinic agonist thas has been approved for use in the treatment of dry mouth and Sjogren's
syndrome, as well as Xerostomia symptoms.